Breaking Research - Medika Life

Advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life - April 27, 2022

Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Fighting Age-Related Macular Degeneration

Michael Hunter, MD - June 30, 2022

A new study confirms supplements slow macular degeneration, an eye condition that can cause blindness.

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

Atefeh Ferdosipour - January 7, 2024

2024, it will be subject to the qualitative and quantitative changes in artificial intelligence.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

Why Healing Still Begins with Relationship

AI in Public Health: Revolution, Risk and Opportunity

HPV Urban Legends – From Contagion to Symptoms to Risks to Prevention – There Are More Rare Concerns that Deserve Our Attention

Researchers Have Stepped Into the Weird World of Science Fiction

LATEST

TRENDING

Were the Billions Invested in Alzheimer’s Research Worthwhile?

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

FDA Approval of New Drug for Alzheimer’s Offers Hope

Texas Tech Professor Invents Game-Changing Ultra Rapid Covid-19 Sensor

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

Central Dogma has Lost its Dog

Aiding and Abetting a Virus

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

Breakthrough Infections Dramatically Enhance COVID Immunity

Research on Controlling Cellular Outposts of the Immune System

EDITORS CHOICE

Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Fighting Age-Related Macular Degeneration

Pursuing Happy Modernity: AI and Human Exploration in New Research-Based Tech

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories